Boomfish Wealth Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Boomfish Wealth Group’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.75M	Sell	5,534 -929	-14%	-$412K	1.25%	31
2026 Q1	$2.89M	Buy	6,463 +53	+0.8%	+$24.7K	1.54%	23
2025 Q4	$2.91M	Sell	6,410 -237	-4%	-$102K	1.55%	25
2025 Q3	$2.6M	Buy	6,647 +1,404	+27%	+$587K	1.4%	32
2025 Q2	$2.33M	Buy	5,243 +192	+4%	+$88.5K	1.35%	34
2025 Q1	$2.45M	Sell	5,051 -41	-0.8%	-$19.1K	1.59%	21
2024 Q4	$2.05M	Buy	5,092 +268	+6%	+$124K	1.24%	36
2024 Q3	$2.24M	Sell	4,824 -151	-3%	-$72.5K	1.38%	35
2024 Q2	$2.33M	Sell	4,975 -107	-2%	-$46.4K	1.51%	27
2024 Q1	$2.12M	Sell	5,082 -350	-6%	-$148K	1.43%	36
2023 Q4	$2.21M	Buy	+5,432	New	+$2.01M	1.6%	25

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Boomfish Wealth Group's VRTX Position: Q2 2026 in Review

Boomfish Wealth Group reduced its Vertex Pharmaceuticals (VRTX) stake by 14% in Q2 2026, selling an estimated $412K and leaving 5,534 shares worth $2.75M. The position accounts for 1.25% of the portfolio, ranked #31.

Boomfish Wealth Group first reported a position in VRTX in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.91M in Q4 2025. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Boomfish Wealth Group held 5,534 shares of Vertex Pharmaceuticals worth $2.75M as of Q2 2026.
Boomfish Wealth Group sold 929 Vertex Pharmaceuticals shares in Q2 2026, an estimated $412K.
Vertex Pharmaceuticals made up 1.25% of Boomfish Wealth Group's portfolio in Q2 2026, its #31 holding.
Boomfish Wealth Group first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
Boomfish Wealth Group's Vertex Pharmaceuticals position peaked at $2.91M in Q4 2025.
1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Boomfish Wealth Group's 13F filing for Q2 2026, filed 4 Aug 2026.